Oct 23, 2026 10:15AM
Oct 19, 2026 07:00AM
Oct 16, 2026 05:15PM
Oct 1, 2026 07:00AM
Oct 1, 2026 07:00AM
Sep 29, 2026 12:12PM
Sep 29, 2026 07:02AM Iovance raises 2026 revenue guidance to $410M-$420M
Sep 29, 2026 07:00AM
Sep 18, 2026 05:10PM
Sep 4, 2026 08:00AM
Aug 21, 2026 05:15PM
Aug 6, 2026 12:31PM
Aug 6, 2026 07:01AM
Jul 30, 2026 08:00AM Iovance Biotherapeutics to Report Second Quarter 2026 Financial Results and Corporate Updates on Thursday, August 6, 2026
Jul 17, 2026 05:15PM
Jun 19, 2026 05:15PM
Jun 3, 2026 04:09PM
Jun 3, 2026 04:05PM
Jun 1, 2026 08:30AM
Jun 1, 2026 07:31AM
Jun 1, 2026 07:30AM Iovance Biotherapeutics Announces Clearance of Investigational New Drug (IND) Application for IL-12 Tethered TIL Therapy IOV-5001
May 22, 2026 05:15PM
May 21, 2026 08:05AM
May 7, 2026 07:05AM
Apr 27, 2026 08:01AM
Apr 17, 2026 05:15PM
Apr 10, 2026 01:20PM
Mar 20, 2026 05:15PM Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Feb 26, 2026 08:00AM
Feb 24, 2026 07:00AM
Feb 24, 2026 07:00AM
Feb 20, 2026 05:15PM
Feb 11, 2026 04:05PM
Feb 5, 2026 05:15PM
Feb 5, 2026 05:15PM Best-in-Class Real-World Data Support Early Amtagvi® Treatment in Advanced Melanoma
Jan 16, 2026 05:15PM
Dec 19, 2025 05:15PM
Nov 21, 2025 05:15PM
Nov 6, 2025 08:00AM
Nov 3, 2025 07:01AM
Nov 3, 2025 07:00AM
Oct 23, 2025 04:05PM Iovance Biotherapeutics to Host Third Quarter 2025 Financial Results and Corporate Updates Webcast on Thursday, November 6, 2025
Oct 17, 2025 05:15PM
Sep 19, 2025 05:00PM
Aug 29, 2025 08:30AM
Aug 22, 2025 05:15PM
Aug 18, 2025 04:15PM
Aug 18, 2025 04:15PM
Aug 7, 2025 04:01PM Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2025
Jul 24, 2025 04:05PM

335,195 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All